We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KKD
451
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$197M 0.04%
10,218,654
-96,550
-0.9% -$1.79M
AMG icon
452
Affiliated Managers Group
AMG
$9.7B
$196M 0.04%
895,639
+646,894
+260% +$144M
CLVS
453
DELISTED
Clovis Oncology, Inc.
CLVS
$196M 0.04%
2,225,637
-49,845
-2% -$4.27M
LYB icon
454
LyondellBasell Industries
LYB
$20.2B
$195M 0.04%
1,888,359
+365,373
+24% +$36.8M
TD icon
455
Toronto Dominion Bank
TD
$203B
$195M 0.04%
4,593,285
+1,500,407
+49% +$67.2M
CME icon
456
CME Group
CME
$96.1B
$194M 0.04%
2,085,752
+305,260
+17% +$28.5M
RF icon
457
Regions Financial
RF
$27B
$193M 0.04%
18,624,345
+209,480
+1% +$2.11M
FRGI
458
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$193M 0.04%
3,857,200
+927,400
+32% +$48.9M
PF
459
DELISTED
Pinnacle Foods, Inc.
PF
$193M 0.04%
4,233,790
-12,560
-0.3% -$531K
BHI
460
DELISTED
Baker Hughes
BHI
$192M 0.04%
3,106,207
+19,918
+0.6% +$1.3M
NXPI icon
461
NXP Semiconductors
NXPI
$58.5B
$192M 0.04%
1,950,488
+598,247
+44% +$61.3M
TRCO
462
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$192M 0.04%
3,587,222
+466,120
+15% +$26M
BRCM
463
DELISTED
BROADCOM CORP CL-A
BRCM
$190M 0.04%
3,690,463
-3,242,494
-47% -$158M
KBR icon
464
KBR
KBR
$4.81B
$190M 0.04%
9,753,600
+693,320
+8% +$12.4M
AON icon
465
Aon
AON
$75.7B
$189M 0.04%
1,896,963
+249,674
+15% +$25M
JOY
466
DELISTED
Joy Global Inc
JOY
$189M 0.04%
5,222,879
+1,500
+0% +$60.4K
RBC icon
467
RBC Bearings
RBC
$17.5B
$189M 0.04%
2,628,459
-100,851
-4% -$7.41M
TXNM
468
TXNM Energy Inc
TXNM
$5.91B
$187M 0.04%
7,596,412
+455,060
+6% +$12.2M
KIM icon
469
Kimco Realty
KIM
$16.4B
$184M 0.04%
8,182,576
-112,080
-1% -$2.74M
GBCI icon
470
Glacier Bancorp
GBCI
$6.48B
$184M 0.04%
6,265,581
-43,815
-0.7% -$1.2M
PRTA icon
471
Prothena Corp
PRTA
$466M
$183M 0.04%
3,475,196
+35,900
+1% +$1.42M
CORE
472
DELISTED
Core Mark Holding Co., Inc.
CORE
$180M 0.04%
6,090,626
+733,426
+14% +$20.8M
CPT icon
473
Camden Property Trust
CPT
$11.1B
$180M 0.04%
2,418,485
+107,433
+5% +$8.13M
GRFS
474
Grifois
GRFS
$5.4B
$178M 0.04%
11,524,894
+1,600,534
+16% +$26M
CKH
475
DELISTED
Seacor Holdings Inc.
CKH
$178M 0.04%
2,588,816
+270,625
+12% +$18.9M

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.